Skip to main content

WPI 3720 (Tranexamic Acid 650 mg)

Pill with imprint WPI 3720 is White, Elliptical/Oval and has been identified as Tranexamic Acid 650 mg. It is supplied by Watson Laboratories, Inc.

Tranexamic acid is used in the treatment of menstrual disorders; menorrhagia; bleeding disorder; factor ix deficiency; hemophilia a and belongs to the drug class miscellaneous coagulation modifiers. There is no proven risk in humans during pregnancy. Tranexamic acid 650 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 3720

Tranexamic Acid

Imprint
WPI 3720
Strength
650 mg
Color
White
Shape
Elliptical/Oval
Availability
Prescription only
Drug Class
Miscellaneous coagulation modifiers
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Laboratories, Inc.
Inactive Ingredients
silicon dioxide, copovidone, crospovidone, glyceryl dibehenate, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, magnesium silicate, triethyl citrate, dimethylaminoethyl methacrylate - butyl methacrylate - methyl methacrylate copolymer

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00591-3720 Watson Pharmaceuticals, Inc.
68084-0929 (Discontinued) Amerisource Health Services

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.